688765 禾元生物
2025/09 - 九个月2024/122023/122022/122017/12

盈利能力分析
净资产收益率 ROE (%)-22.083-22.711-22.984-32.075-34.227
总资产报酬率 ROA (%)-9.602-14.957-18.109-26.042-27.582
投入资产回报率 ROIC (%)-12.523-18.269-21.466-31.449-31.504

边际利润分析
销售毛利率 (%)50.08663.48954.26963.58716.880
营业利润率 (%)-616.816-600.283-770.655-1,060.405-877.421
息税前利润/营业总收入 (%)-596.453-588.876-790.906-1,181.568-871.144
净利润/营业总收入 (%)-616.816-600.283-770.533-1,071.488-874.805

收益指标分析
经营活动净收益/利润总额(%)109.233111.598107.861102.413111.501
价值变动净收益/利润总额(%)0.0000.0000.0000.0000.000
营业外收支净额/利润总额(%)0.0000.000-0.0161.034-0.299

偿债能力分析
流动比率 (X)0.6411.0202.3922.3501.524
速动比率 (X)0.3590.8052.0962.2151.040
资产负债率 (%)66.05643.36623.96418.81019.476
带息债务/全部投入资本 (%)50.44922.1039.3521.5730.109
股东权益/带息债务 (%)88.862328.494943.7786,233.15185,335.655
股东权益/负债合计 (%)51.387130.596317.298431.644413.443
利息保障倍数 (X)-29.291-51.62238.82110.734-237.939

营运能力分析
应收账款周转天数 (天)3.6242.4742.1662.41522.494
存货周转天数 (天)2,145.5661,676.400995.8801,893.558945.124